Who
Margaret McLoughlin
Director
Company insider
Files Form 4 as: Director, Quince Therapeutics.
In numbers
- Trades disclosed
- 25
- Buys
- 2
- Sells
- 3
- Bought
- $19K
- Sold
- $692K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 8 May 2019
- Last trade
- 2 Jan 2026
- Last filed
- 21 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 21 Jan 2026 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,547 at $0.00 | filing |
| 2 Jan 2026filed 21 Jan 2026 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,547 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 2 Jan 2025filed 8 Jan 2025 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —31,613 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 8 Aug 2023filed 9 Aug 2023 | Quince TherapeuticsBiotechnology | SEC FORM 4 Bought | $9,8408,000 at $1.23 | filing |
| 24 May 2023filed 26 May 2023 | Quince Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 8 Jun 2022filed 9 Jun 2022 | IRLA IRulya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 8 Oct 2021filed 12 Oct 2021 | IRLA IRulya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 8 Oct 2021filed 12 Oct 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Code M | $17K1,000 at $17.00 | filing |
| 8 Oct 2021filed 12 Oct 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Sold | $89K1,000 at $88.93 | filing |
| 16 Aug 2021filed 18 Aug 2021 | IRLA IRulya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
| 16 Aug 2021filed 18 Aug 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Code M | $102K6,000 at $17.00 | filing |
| 16 Aug 2021filed 18 Aug 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Sold | $289K3,056 at $94.55 | filing |
| 16 Aug 2021filed 18 Aug 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Sold | $100K1,044 at $95.57 | filing |
| 16 Aug 2021filed 18 Aug 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Sold | $138K1,429 at $96.51 | filing |
| 16 Aug 2021filed 18 Aug 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Sold | $41K423 at $97.55 | filing |
| 16 Aug 2021filed 18 Aug 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,74748 at $98.90 | filing |
| 28 Jun 2021filed 29 Jun 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Sold | $11K200 at $55.01 | filing |
| 28 Jun 2021filed 29 Jun 2021 | IRLA IRulya TherapeuticsBiotechnology | SEC FORM 4 Sold | $14K250 at $55.03 | filing |
News
IRulya Therapeutics to Participate in the Craig-Hallum Biotech Catalyst ConferenceIRLA · manilatimes.net · 15 Oct 2026
0 headlines in the last 90 days name Margaret McLoughlin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.